Cancer Research Targets  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stemmer-Rachamimov, A. O.
Right arrow Articles by Giovannini, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stemmer-Rachamimov, A. O.
Right arrow Articles by Giovannini, M.
[Cancer Research 64, 3718-3724, May 15, 2004]
© 2004 American Association for Cancer Research


Meeting Report

Comparative Pathology of Nerve Sheath Tumors in Mouse Models and Humans

Anat O. Stemmer-Rachamimov1, David N. Louis1,14, Gunnlaugur P. Nielsen1, Cristina R. Antonescu3, Alexander D. Borowsky4, Roderick T. Bronson5, Dennis K. Burns6, Pascale Cervera8, Margaret E. McLaughlin9, Guido Reifenberger10, Michael C. Schmale11, Mia MacCollin2, Richard C. Chao12, Karen Cichowski13, Michel Kalamarides8, Shanta M. Messerli2, Andrea I. McClatchey14, Michiko Niwa-Kawakita8, Nancy Ratner15, Karlyne M. Reilly16, Yuan Zhu7,17 and Marco Giovannini8

1 Departments of Pathology and 2 Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; 3 Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York; 4 Medical Pathology Center for Comparative Medicine, University of California at Davis, Davis, California; 5 Department of Pathology, Harvard Medical School, Boston, Massachusetts; 6 Department of Pathology and 7 Center for Developmental Biology, University of Texas Southwestern Medical Center, Dallas, Texas; 8 INSERM U434, Fondation Jean Dausset-CEPH, Paris, France; 9 Department of Pathology, Brigham and Women’s Hospital, Boston, Massachusetts; 10 Department of Neuropathology, Heinrich-Heine-University, Duesseldorf, Germany; 11 Division of Marine Biology and Fisheries, Rosenstiel School of Marine and Atmospheric Science, University of Miami, Miami, Florida; 12 Department of Medicine, Veterans’ Affairs Medical Center and University of California at San Francisco, San Francisco, California; 13 Genetics Division, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts; 14 Massachusetts General Hospital Cancer Center, Harvard Medical School Department of Pathology, Charlestown, Massachusetts; 15 Department of Cell Biology, Neurobiology, and Anatomy, University of Cincinnati College of Medicine, Cincinnati, Ohio; 16 Genetic Modifiers of Tumorigenesis Section, Mouse Cancer Genetics Program, National Cancer Institute at Frederick, Frederick, Maryland; and 17 Division of Molecular Medicine and Genetics, University of Michigan Medical School, Ann Arbor, Michigan

ABSTRACT

Despite the progress made in our understanding of the biology of neurofibromatosis (NF), the long-term clinical outcome for affected patients has not changed significantly in the past decades, and both NF1 and NF2 are still associated with a significant morbidity and a decreased life span. A number of NF1 and NF2 murine models have been generated to aid in the study of NF tumor biology and in the development of targeted therapies for NF patients. A single, universal pathological classification of the lesions generated in these murine models is essential for the validation of the models, for their analysis and comparison with other models, and for their future effective use in preclinical treatment trials. For the formulation of a pathological classification of these lesions, the WHO classification of human tumors was used as a reference. However, it was not adopted for the classification of the GEM lesions because of some important differences between the human and murine lesions. A novel classification scheme for peripheral nerve sheath tumors in murine models was therefore devised.




This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
L. S Kirschner, Z. Yin, G. N Jones, and E. Mahoney
Mouse models of altered protein kinase A signaling
Endocr. Relat. Cancer, September 1, 2009; 16(3): 773 - 793.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. M. Reilly, K. W. Broman, R. T. Bronson, S. Tsang, D. A. Loisel, E. S. Christy, Z. Sun, J. Diehl, D. J. Munroe, and R. G. Tuskan
An Imprinted Locus Epistatically Influences Nstr1 and Nstr2 to Control Resistance to Nerve Sheath Tumors in a Neurofibromatosis Type 1 Mouse Model
Cancer Res., January 1, 2006; 66(1): 62 - 68.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
A. I. McClatchey and M. Giovannini
Membrane organization and tumorigenesis--the NF2 tumor suppressor, Merlin
Genes & Dev., October 1, 2005; 19(19): 2265 - 2277.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. S. Kirschner, D. F. Kusewitt, L. Matyakhina, W. H. Towns II, J. A. Carney, H. Westphal, and C. A. Stratakis
A Mouse Model for the Carney Complex Tumor Syndrome Develops Neoplasia in Cyclic AMP-Responsive Tissues
Cancer Res., June 1, 2005; 65(11): 4506 - 4514.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.